Anastrozole

CAS 120511-73-1 17 current records 10 historicalSmall Molecule

Who holds supplier records for Anastrozole? 17 organisations hold a current record for Anastrozole: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (3), Taiwan (2), Netherlands (2) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Anastrozole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/anastrozole

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Anastrozole. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Anastrozole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Anastrozole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
WANYANG HENGSHUI PHARMACEUTICAL CO. LTD HengshuiCN
CEP 2026-059 - Rev 00
Anastrozole, Micronised
Sept 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2013-172 - Rev 02
Anastrozole, Form-II
Oct 2025—
MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED TarapurIN
CEP 2025-063 - Rev 00
Anastrozole
Aug 2025Inspected Oct 2023
Switzerland, outside 3-year window
TAPI NL B.V. AmsterdamNL
CEP 2014-099 - Rev 02
Anastrozole
Jan 2025—
SCINOPHARM TAIWAN LTD. Shan-HuaTW
CEP 2014-128 - Rev 01
Anastrozole
Sept 2024—
EXCELLA GMBH & CO. KG FeuchtDE
CEP 2024-160 - Rev 00
Anastrozole, Milled and micronised (Z); modified process
Aug 2024Inspected Apr 2026
Germany
SYNTHIMED LABS PRIVATE LIMITED DerabassiIN
CEP 2013-140 - Rev 01
Anastrozole
Aug 2024Inspected Aug 2026
Slovenia
SICHUAN XIELI PHARMACEUTICAL CO., LTD. PengzhouCN
CEP 2017-114 - Rev 01
Anastrozole
Jul 2024—
SYNTHON BV NijmegenNL
R1-CEP 2015-254 - Rev 00
Anastrozole
Mar 2022—
NATCO PHARMA LIMITED HyderabadIN
R1-CEP 2014-022 - Rev 00
Anastrozole
Jan 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Anastrozole are no longer active. These show a past filing, not current supply.

Show all 10 historical records

Overview

Anastrozole is a non-steroidal aromatase inhibitor used primarily to treat estrogen receptor-positive breast cancer by reducing estrogen levels in the body. It is particularly effective in postmenopausal women.

Chemical identity

IUPAC name
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
Canonical SMILES
CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
InChIKey
YBBLVLTVTVSKRW-UHFFFAOYSA-N
Synonyms
Arimidex API, anastrozole, Arimidex, anastrazole, Anastrozol, ZD1033, ZD-1033, ICI D1033, ICI-D1033, ZD 1033, Rvg-106400, NSC719344

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Aromatase Inhibitor
Mechanism of action
Aromatase Inhibitors

Therapeutic areas

OncologyEndocrinology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Anastrozole?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Anastrozole: EXCELLA GMBH AND CO KG (Germany), Hetero Labs Limited (India), Natco Pharma (India), SCINOPHARM TAIWAN LTD (Taiwan), SYNTHIMED LABS PRIVATE LIMITED (India), TAPI NL BV (Netherlands), WANYANG HENGSHUI PHARMACEUTICAL CO LTD (China) and Apotex Inc. (Canada), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Anastrozole Drug Master Files are active?

EXCELLA GMBH AND CO KG (DMF 20338), Hetero Labs Limited (DMF 22231), Natco Pharma (DMF 19687), SCINOPHARM TAIWAN LTD (DMF 18335), SYNTHIMED LABS PRIVATE LIMITED (DMF 25308), TAPI NL BV (DMF 19034), WANYANG HENGSHUI PHARMACEUTICAL CO LTD (DMF 40305) and Apotex Inc. (DMF 23326) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Anastrozole records mean?

10 organisations have only inactive Type II DMFs for Anastrozole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Anastrozole have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Anastrozole on the EDQM register, including WANYANG HENGSHUI PHARMACEUTICAL CO. LTD Hengshui (CN), HETERO LABS LIMITED Hyderabad (IN), MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED Tarapur (IN), TAPI NL B.V. Amsterdam (NL), SCINOPHARM TAIWAN LTD. Shan-Hua (TW) and EXCELLA GMBH & CO. KG Feucht (DE) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Anastrozole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Anastrozole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.